Skip to main content
Joshua Field, MD, Oncology, Milwaukee, WI

JoshuaJFieldMD

Oncology Milwaukee, WI

Assistant Professor, Medicine, Medical College of Wisconsin

Dr. Field is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Field's full profile

Already have an account?

  • Office

    9200 W Wisconsin Ave
    # Division
    Milwaukee, WI 53226
    Phone+1 414-805-6800
    Fax+1 414-805-6808

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Blood Banking/Transfusion Medicine, 2005 - 2006
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2001 - 2004
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2010 - 2025
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicent...
    Joshua J. Field, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry
    Joshua J. Field, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the GRNDaD Registry 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • New Sickle Cell Anemia Therapy Advances to Phase II Clinical Trials
    New Sickle Cell Anemia Therapy Advances to Phase II Clinical TrialsJune 12th, 2013